River Road Asset Management, an investment management company released its “River Road Mid Cap Value Fund” Q4 2024 investor ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Centene’s shares (currently trading at $60.25) have posted a disappointing 18.2% loss while the S&P 500 was flat. This may ...

Centene's business transformation and strategic focus on core segments led to increased operational marginality. Read why I ...

Centene CNC has outperformed the market over the past 20 years by 2.69% on an annualized basis producing an average annual ...

Analysts have set 12-month price targets for Cigna Group, revealing an average target of $366.0, a high estimate of $390.00, ...

With a focus on innovation and growth, Centene continues to expand its influence in the managed healthcare sector. However, in the longer term, CNC stock has declined 21.5% over the past 52 weeks ...

Centene Corporation CNC recently unveiled that ... Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous ...

Centene Corporation reported strong Q4 '24 results, with EPS of $0.80 and management raised 2025 revenue guidance by $4 billion. Read why I rate CNC stock a buy.

Detailed price information for Clover Health Investments Corp (CLOV-Q) from The Globe and Mail including charting and trades.

For many investors, the main point of stock picking ... three years, Centene actually managed to grow EPS by 42% per year in that time. Given the share price reaction, one might suspect that EPS is ...